← Back
Data updated: Mar 10, 2026
SICOR PHARMS
OncologyInfectious DiseaseDermatology
SICOR PHARMS is a pharmaceutical company focused on Oncology, Infectious Disease, Dermatology.
-
Since
1
Drugs
-
Trials
31
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LEVOFLOXACIN 2024-09-20
Labeling
LEVOFLOXACIN 2024-09-20
Labeling
LEVOFLOXACIN 2024-09-20
Labeling
LEVOFLOXACIN 2024-09-20
Labeling
LEVOFLOXACIN 2024-09-20
Labeling
LEVOFLOXACIN 2024-09-20
Labeling
LEVOFLOXACIN 2024-09-20
Labeling
LEVOFLOXACIN 2024-09-20
Labeling
LEVOFLOXACIN 2024-09-20
Labeling
LEVOFLOXACIN 2024-09-20
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 52%
0 drugs Phase 3: 3 Phase 1: 2
Infectious Disease 30%
0 drugs Phase 3: 1 Phase 2: 2
Dermatology 19%
0 drugs Phase 3: 1 Phase 1: 1
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Oncology, Dermatology
COSETTE other
Dermatology, Infectious Disease, Oncology
KING PHARMS LLC big-pharma
Infectious Disease, Dermatology, Oncology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology